These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35818450)

  • 41. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
    Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
    PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study.
    Elduma AH; Mansournia MA; Foroushani AR; Ali HMH; Elegail AMA; Elsony A; Holakouie-Naieni K
    Epidemiol Health; 2019; 41():e2019014. PubMed ID: 31010280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.
    Okethwangu D; Birungi D; Biribawa C; Kwesiga B; Turyahabwe S; Ario AR; Zhu BP
    BMC Infect Dis; 2019 May; 19(1):387. PubMed ID: 31064332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of psychological distress and associated factors among adult tuberculosis patients attending public health institutions in Dire Dawa and Harar cities, Eastern Ethiopia.
    Ayana TM; Roba KT; Mabalhin MO
    BMC Public Health; 2019 Oct; 19(1):1392. PubMed ID: 31660912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia.
    Bykov I; Dyachenko O; Ratmanov P; Liu H; Liang L; Wu Q
    BMC Infect Dis; 2022 Jul; 22(1):612. PubMed ID: 35831812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.
    Stosic M; Vukovic D; Babic D; Antonijevic G; Foley KL; Vujcic I; Grujicic SS
    BMC Public Health; 2018 Sep; 18(1):1114. PubMed ID: 30208864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
    Suryavanshi N; Murrill M; Gupta A; Hughes M; Hesseling A; Kim S; Naini L; Jones L; Smith B; Gupte N; Dawson R; Mave V; Meshram S; Mendoza-Ticona A; Sanchez J; Kumarasamy N; Comins K; Conradie F; Shenje J; Nerette Fontain S; Garcia-Prats A; Asmelash A; Nedsuwan S; Mohapi L; Lalloo U; Cristina Garcia Ferreira A; Okeyo E; Swindells S; Churchyard G; Shah NS
    Clin Infect Dis; 2020 Jan; 70(3):436-445. PubMed ID: 30919881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
    Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
    BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of tuberculosis infection among adults visiting anti-retroviral treatment center at east and west Gojjam, northwest, Ethiopia, 2017.
    Belew H; Wubie M; Tizazu G; Bitew A; Birlew T
    BMC Infect Dis; 2020 Aug; 20(1):593. PubMed ID: 32787798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia.
    Alene KA; Viney K; McBryde ES; Clements AC
    PLoS One; 2017; 12(2):e0171800. PubMed ID: 28182726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study.
    Mulu W; Abera B; Yimer M; Hailu T; Ayele H; Abate D
    BMC Res Notes; 2017 Jan; 10(1):8. PubMed ID: 28057041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of Health Related Quality of Life in Eastern Ethiopia.
    Roba AA; Dasa TT; Weldegebreal F; Asfaw A; Mitiku H; Teklemariam Z; Naganuri M; Geddugol BJ; Mesfin F; Befikadu H; Tesfaye E
    PLoS One; 2018; 13(10):e0204697. PubMed ID: 30321189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: An institution-based cross-sectional study.
    Mengesha MM; Gebremichael MA; Watumo D; Hallström IK; Jerene D
    PLOS Glob Public Health; 2022; 2(3):e0000161. PubMed ID: 36962264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome.
    Girum T; Muktar E; Lentiro K; Wondiye H; Shewangizaw M
    Trop Dis Travel Med Vaccines; 2018; 4():5. PubMed ID: 29942536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study.
    Htun YM; Khaing TMM; Yin Y; Myint Z; Aung ST; Hlaing TM; Soonthornworasiri N; Silachamroon U; Kasetjaroen Y; Kaewkungwal J
    BMC Health Serv Res; 2018 Nov; 18(1):878. PubMed ID: 30458776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019.
    Song WM; Guo J; Xu TT; Li SJ; Liu JY; Tao NN; Liu Y; Zhang QY; Liu SQ; An QQ; Li YF; Yu CB; Dong JH; Li HC
    BMC Pulm Med; 2021 Dec; 21(1):399. PubMed ID: 34872558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis.
    Naz F; Ahmad N; Wahid A; Ahmad I; Khan A; Abubakar M; Khan SA; Khan A; Latif A; Ghafoor A
    BMC Infect Dis; 2021 Dec; 21(1):1209. PubMed ID: 34863099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genotyping and molecular detection of multidrug-resistant
    Zewdie O; Mihret A; Abebe T; Kebede A; Desta K; Worku A; Ameni G
    New Microbes New Infect; 2018 Jan; 21():36-41. PubMed ID: 29675262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015-2019.
    Wasihun AG; Hailu GG; Dejene TA
    Infect Dis Ther; 2021 Sep; 10(3):1299-1308. PubMed ID: 33950463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.